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设计和搭建了一套改进的 PGSS 装置，相比于已报导的 PGSS 工艺，该装置





利用改进的装置，分别用超临界 CO2 和 N2 辅助下的 PGSS 方法进行肉豆蔻








利用改进的实验装置，用 CO2 辅助的 PGSS 方法制备了 CoQ10/肉豆蔻酸（脂）
和 CoQ10/PEG6000(高分子)胶囊，考察了操作条件对形成的微胶囊的影响，也考

















没有影响，但温度的升高会导致粒径分布变宽；当 CoQ10 含量达到 70%，粒径分
布出现聚集峰。微胶囊中 CoQ10 的光稳定性分析表明制备的 CoQ10 微胶囊具有良
好的避光性；溶出度结果表明该微胶囊对 CoQ10 没有增溶或缓释作用。制备的
CoQ10/PEG6000 微胶囊为丝状和球状，当微胶囊置于水中时，PEG6000 溶解于
水中，得到平均粒径为 190nm 的 CoQ10。微胶囊中 CoQ10 的光稳定性分析表明
制备的 CoQ10 微胶囊同样具有良好的避光性；溶出度结果发现，制备的微胶囊（含
10%CoQ10）10h 释放了约 40%的 CoQ10，表明所该微胶囊对 CoQ10 具有较好的增
溶效果。 
利用改进的 PGSS 实验装置，用 CO2 辅助的 PGSS 方法制备了薄荷醇/蜡微
胶囊，结果表明：预膨胀压力越高，微胶囊颗粒平均粒径变小、粒径分布变窄，


























PGSS (particles from gas-saturated solution) is a promising supercritical fluid 
(SCF)-assisted technique in preparing fine particles and microcapsules /microspheres. 
PGSS technique has some significant advantages over traditional methods in 
preparation of fine particles such as low energy comsumption, environment-friendly 
process, preferable particle morphology, and controllable particle size and particle 
size distribution. In the context of microcapsules /microspheres, the technique can 
also provide high encapsulation efficiency. This thesis focuses on the modification of 
conventional PGSS processes reported in literature and the applications of the 
modified process in pharmaceutics and flavors. 
A modifed PGSS apparatus was designed and built. In comparison to 
conventional PGSS processes, it has several advantages: N2 and CO2 can be 
independently used or mixed (CO2 used as a solute and N2 used as the atomizing gas); 
a two-way nozzle is used to prevent the noozle from blocking and improve the 
atomization; a circulation section is constructed to increase the contact of raw 
materials and supercritical fluids, shortening the time of formation of gas-saturated 
solution; a continuous pump is installed to control the flowrate of the solution. 
The modified PGSS process with CO2 (CO2-assisted process) and N2 (N2- 
assisted process) was implemented for myristic acid, and nano- or/and microparticles 
were produced. The pre-expansion pressure shows obvious effect on the process: 
higher pressure produces smaller particles. The pre-expansion temperature shows no 
obvious effect on the produced particles’ size, but agglomerated particles formed at 
relatively high temperatures. When the flowrate increases, the average particle size 
increases slightly and particle size distribution broadens. DSC results show that the 
produced particles have small particle sizes. The produced particles from the 
CO2-assisted process are flakes with a trimodal particle size distribution, indicating 
that the particles are from RESS process (solution crystallization), atomization (melt 
crystallization), and aggregation of fine particles. The produced particles from the 















only atomization occurs in the process. 
CoQ10/myristic acid (lipid) microspheres and CoQ10/PEG6000 (polymer) 
microspheres were produced from the CO2-assisted process by using the modified 
apparatus. Results show that the produced microspheres of CoQ10 /myristic acid are 
flakes when the content of CoQ10 is low. As the pre-expansion pressure increases, the 
produced particles’ size decreases, while particle sise distribution broadens. The 
pre-expansion temperature and the flowrate show no obvious effect on the average 
particle size, but the particle size distribution broadens when the temperature 
increases. As the content of CoQ10 reaches 70%, the produced microspheres become 
agglomerated. The dissolution test shows that myristic acid has no obvious effect on 
the release of CoQ10 from the CoQ10/myristic acid microspheres in aqueous solution 
(CoQ10 release is less than 5% in 12h). The produced CoQ10/PEG6000 microspheres 
with 10% CoQ10 are irregular, and particles with an average particle size of 190nm 
were obtained when the microspheres were dispersed into water. The dissolution test 
shows that the CoQ10 release from the CoQ10/PEG6000 microspheres in aqueous 
solution is dramatically enhanced (release of 40% CoQ10 in 10h). The study of light 
stability shows that both the CoQ10/myristic acid and CoQ10/PEG6000 microspheres 
have obvious protection of CoQ10 from light. 
Menthol/wax microspheres were produced from the CO2-assisted process by 
using the modified PGSS apparatus. Particle size decreases and particle size 
distribution becomes norrow as the pre-expansion pressure increases: the particle size 
is in the range 2-30μm under 15 and 20MPa; agglomerated particles can be observed 
at low pressures. Particle size decreases and article size distribution becomes broad as 
the flowrate increases: the particle size is in the range 2-50μm under studied flowrates. 
Encapsulation efficicency and particle size decrease, particle size distribution 
becomes broad as the menthol content increases: the particle size is in the range 
2-50μm under studied menthol contents. Pre-expansion pressure and flowrate show 
no effect on the encapsulation efficicency. Retention measurement shows that the 
microspheres have obvious protection of menthol from its volatilization loss. 
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流体，如图 1-1 所示的是 CO2 相图，右上角即为 CO2 的超临界区域。 
 
Fig. 1-1 Phase diagram of CO2 [1] 
 
SCF 与其它流体（气体和液体）的主要物性（密度、粘度和扩散系数）的比












































































微胶囊技术的研究大约始于 20 世纪 30 年代，大西洋海岸渔业公司提出制
备鱼肝油－明胶微囊的方法。40 年代末美国学者 Wurseter 利用机械方法制备微
胶囊，并成功用于药物包衣，至今仍把空气悬浮法称为 Wurseter 法[14]。1950 年
通用邓洛普公司提出双层锐孔技术制备海藻酸钠微胶囊的专利，从此各种制备微
胶囊的方法层出不穷。1957 年穆尔企业提出喷雾干燥法制备微胶囊。50 年代微
胶囊技术取得 大成果的是美国 NCR 公司的 Green，他利用物理化学原理发明
了相分离复合凝聚法（化学法）制备含油的明胶微胶囊，并用于制备无碳复写纸，
取得巨大成功。60 年代，兴起了用许多高分子聚合反应为基础的化学方法制备

























1.3 SCF 制备微粒技术分类及原理 
目前 SCF 制备微粒技术（均可实现微胶囊的制备）有以下研究比较深入的
几类[17, 18]：超临界流体快速膨胀过程（Rapid Expansion of Supercritical Solutions, 
RESS ）、超临界流体抗溶剂结晶过程（ Gas or Supercritical Anti-solvent 
Crystallization, GAS or SAS）和气体饱和溶液微粒形成技术（The Particles from 












细颗粒所不能解决的难题。能够制备出平均粒径在 1μm 以下的微粒是 RESS 
具优势的地方。但事实上，根据理论计算，从出口处形成的颗粒粒径可以更小，
可以达到 20nm 的细小程度。实际粒径比理论值大的主要原因是 RESS 通常存
在微粒聚集的现象。RESS 不仅可以用来微粒化纯品物质，也可以用于制备药物




























Fig. 1-2 Schematic diagram of a typical PGSS process [26] 
 
1.3.2.2 研究进展 
PGSS 早由Weidner于1994年提出[27, 28]，但早在1979年就有人涉及到PGSS 
技术的雏型[18]。 近几年 PGSS 技术发展迅猛，人们开始认识到的该技术潜在的
应用价值。Jung 等[18]、Knez 等[29] 认为，由于 PGSS 的过程简单而具有更加广
泛的用途，多种物质（液滴、固体材料、液体溶液、悬浮液等）均能用 PGSS 处
理。此外，由 PGSS 技术衍生出许多与其相似的过程，如美国的 Sievers 教授[30]
的二氧化碳辅助雾化鼓泡干燥（Carbon dioxide Assisted Nebulization with a Bubble 
Dryer, CAN-BD）；意大利的 Reverchon 教授 [31]的超临界流体辅助雾化技术
(Supercritical-Assisted Atomization, SAA)；西班牙的 Ventosa[32]等人提出的膨胀有
机溶液卸压技术（Depressurization of an Expanded Organic Solution, DELOS）。 
PGSS 技术在微胶囊化方面的应用近几年也得到研究人员的关注。Weinder
课题组在研究 PEG 的微粒化的基础上，进行了 PEG 包裹药物的研究[28]。葡萄牙
的 Azevedo 教授课题组[33~35]研究了氢化棕榈油（HPO）包裹药物。Sousa 等[36]
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